Pharmaceutical Research and Manufacturers of America (PhRMA) Sustainability

PhRMA represents the nation's leading biopharmaceutical research companies. The organization works to drive patient-centered progress in innovation, affordability, and access to life-saving prescription medicines. PhRMA member companies have invested over $850 billion in developing new treatments and cures over the past decade. The organization is committed to ethical relationships and behavior in developing and delivering medicines to help patients live longer and healthier lives.

R&D Investment in New Treatments

Over the past decade, PhRMA member companies have invested over $850 billion in developing new treatments and cures, yielding groundbreaking results.

U.S. Manufacturing Investments

PhRMA member companies are making historic investments in U.S.-based manufacturing and infrastructure, providing financial assistance to support domestic production.

Pharmaceutical Research and Manufacturers of America (PhRMA) Sustainability Profile

About Pharmaceutical Research and Manufacturers of America (PhRMA)